Report DMCA Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metasta
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.